ID   S18
SY   CNE-2 Clone-18; Clone-18
DR   Wikidata; Q108821256
RX   Patent=CN109536452A;
RX   PubMed=17062557;
RX   PubMed=25028967;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6889 ! CNE-2
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
RX   Patent=CN109536452A;
RA   Li C.-Z., Qian C.-N., Chen J.-D., Zhou H.-J., Hao D.-L.;
RT   "A visualized nasopharyngeal carcinoma cell and its application.";
RL   Patent number CN109536452A, 29-Mar-2019.
RX   PubMed=17062557; DOI=10.1158/0008-5472.CAN-06-2977;
RA   Qian C.-N., Berghuis B., Tsarfaty G., Bruch M., Kort E.J., Ditlev J.,
RA   Tsarfaty I., Hudson E., Jackson D.G., Petillo D., Chen J.-D.,
RA   Resau J.H., Teh B.T.;
RT   "Preparing the 'soil': the primary tumor induces vasculature
RT   reorganization in the sentinel lymph node before the arrival of
RT   metastatic cancer cells.";
RL   Cancer Res. 66:10365-10376(2006).
RX   PubMed=25028967; DOI=10.1371/journal.pone.0100843;
RA   Liang Y.-Y., Chen M.-Y., Hua Y.-J., Chen S., Zheng L.-S., Cao X.,
RA   Peng L.-X., Xie P., Huang B.-J., Sun R., Wang L., Xiang Y.-Q., Guo X.,
RA   Qian C.-N.;
RT   "Downregulation of Ras association domain family member 6 (RASSF6)
RT   underlies the treatment resistance of highly metastatic nasopharyngeal
RT   carcinoma cells.";
RL   PLoS ONE 9:E100843-E100843(2014).